Lakewood-Amedex Biotherapeutics Announces World-Renowned Expert David G. Armstrong, M.D., Ph.D., as Study Chair for Phase 2a Trial of Nu-3 in Infected Diabetic Foot Ulcers
Go back to Lakewood-Amedex Biotherapeutics Announces World-Renowned Expert David G. Armstrong, M.D., Ph.D., as Study Chair for Phase 2a Trial of Nu-3 in Infected Diabetic Foot Ulcers| (NASDAQ: LABT) | Delayed: 3.02 -0.39 (11.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.41 | 52 Week High | $ | |||
| Open | $3.55 | 52 Week Low | $ | |||
| Day High | $3.55 | P/E | N/A | |||
| Day Low | $2.77 | EPS | $ | |||
| Volume | 1,916,340 | |||||
